Statistics for Cutting-edge: preclinical and clinical development of the first approved LAG-3 inhibitor
Total visits
| views | |
|---|---|
| Cutting-edge: preclinical and clinical development of the first approved LAG-3 inhibitor | 199 |
Total visits per month
| views | |
|---|---|
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 1 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
File Visits
| views | |
|---|---|
| Chocarro_CuttingEdge_1669631111932_42077.pdf | 167 |
| Chocarro_Cutting.Edge_MatCompl_1672385633884.zip | 52 |
Top country views
| views | |
|---|---|
| United States | 103 |
| China | 19 |
| South Korea | 8 |
| Spain | 7 |
| Iran | 5 |
| Sweden | 4 |
| Canada | 3 |
| Vietnam | 3 |
| France | 2 |
| India | 2 |
| Turkey | 2 |
| Czechia | 1 |
| Hong Kong SAR China | 1 |
| Ireland | 1 |
| Pakistan | 1 |
| Puerto Rico | 1 |
| Saudi Arabia | 1 |
| Singapore | 1 |
Top city views
| views | |
|---|---|
| Ashburn | 24 |
| Houston | 12 |
| Oakland | 12 |
| Fairfield | 8 |
| Guangzhou | 8 |
| Mountain View | 7 |
| San Diego | 7 |
| Cambridge | 5 |
| Ann Arbor | 3 |
| Hanoi | 3 |
| Beijing | 2 |
| Chicago | 2 |
| Falls Church | 2 |
| Fuzhou | 2 |
| Jinan | 2 |
| Kolkata | 2 |
| Menlo Park | 2 |
| Pamplona | 2 |
| Redmond | 2 |
| Seoul | 2 |
| Absecon | 1 |
| Baltimore | 1 |
| Brno | 1 |
| Bronx | 1 |
| Central District | 1 |
| Ciudad Real | 1 |
| Durham | 1 |
| Encino | 1 |
| Islamabad | 1 |
| Istanbul | 1 |
| Kansas City | 1 |
| Konya | 1 |
| Las Vegas | 1 |
| Lleida | 1 |
| Málaga | 1 |
| Paris | 1 |
| Pomona | 1 |
| Rochester | 1 |
| Saskatoon | 1 |
| Scottsdale | 1 |
| South Hadley | 1 |
| Tampa | 1 |
| Tehran | 1 |
| Whitby | 1 |
| Wilmington | 1 |
| Zhengzhou | 1 |